Investment
Features
FeesSafety
Academy
More
Pluang+

Toast launches AI marketing tool Toast IQ Grow, boosting restaurant insights and Q1 2026 revenue up 21.9%.

Company Fundamentals
01 Jul 2026
Seeking Alpha
View Source
Bullish
pluang ai news

Toast introduced Toast IQ Grow, an AI-driven marketing solution designed to help restaurant operators tackle daily marketing challenges using its extensive first-party data. The product has quickly gained traction, reaching 40,000 weekly active locations and providing actionable insights that could drive further adoption. In Q1 2026, Toast's revenue rose 21.91% year-over-year to $1.63 billion, with improved profitability despite slightly missing revenue estimates. This innovation positions Toast to enhance engineering productivity and create new premium revenue streams moving forward.

More News

Valeo to redeem €750M bonds early on August 24, 2026, under make-whole redemption option.

Valeo to redeem €750M bonds early on August 24, 2026, under make-whole redemption option.

Valeo SE has announced it will exercise its option to redeem €750 million of its 5.375% bonds maturing in May 2027 early, with the redemption date set for August 24, 2026. This make-whole redemption means bondholders will receive a calculated amount ...

Company Fundamentals
Neutral
57 minutes ago
Valeo to redeem €750M sustainability-linked bonds early on August 24, 2026

Valeo to redeem €750M sustainability-linked bonds early on August 24, 2026

Valeo SE announced it will exercise its make-whole redemption option to redeem in full its €750 million 5.375% sustainability-linked bonds due May 2027. The redemption will occur on August 24, 2026, ahead of the original maturity date, with the redem...

Company Fundamentals
Neutral
57 minutes ago
Nxera Pharma reports Q2 2026 profit on milestone payments and advances in drug development.

Nxera Pharma reports Q2 2026 profit on milestone payments and advances in drug development.

Nxera Pharma announced a net profit of JPY 1,591 million (US$10.1 million) for Q2 2026, reversing a prior loss due to multiple milestone payments from partners like Neurocrine, AbbVie, and Lilly. The company progressed regulatory approvals and commer...

Company Fundamentals
Bullish
59 minutes ago
Bekaert repurchases 50,500 shares and updates on liquidity agreement for early August 2026.

Bekaert repurchases 50,500 shares and updates on liquidity agreement for early August 2026.

Between July 30 and August 5, 2026, Bekaert repurchased 50,500 of its own shares worth nearly €2 million as part of its ongoing €75 million buyback program, with all repurchased shares planned for cancellation. Additionally, under its liquidity agree...

Company Fundamentals
Neutral
1 hour ago
Bekaert repurchases 50,500 shares and updates on liquidity agreement for early August 2026

Bekaert repurchases 50,500 shares and updates on liquidity agreement for early August 2026

Between July 30 and August 5, 2026, Bekaert repurchased 50,500 shares as part of its €75 million share buyback program, aiming to cancel all repurchased shares. The average price paid was €39.40 per share, totaling nearly €2 million. Additionally, un...

Company Fundamentals
Neutral
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App